These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31779925)

  • 1. Heart Failure Prevention in Older Patients Using Intensive Blood Pressure Reduction: Potential Role of Diuretics.
    Upadhya B; Lovato LC; Rocco M; Lewis CE; Oparil S; Cushman WC; Kostis JB; Rodriguez CJ; Cho ME; Cloud LW; Rastogi A; Rosendorff C; Kitzman DW;
    JACC Heart Fail; 2019 Dec; 7(12):1032-1041. PubMed ID: 31779925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Intensive Blood Pressure Treatment on Heart Failure Events in the Systolic Blood Pressure Reduction Intervention Trial.
    Upadhya B; Rocco M; Lewis CE; Oparil S; Lovato LC; Cushman WC; Bates JT; Bello NA; Aurigemma G; Fine LJ; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
    Circ Heart Fail; 2017 Apr; 10(4):. PubMed ID: 28364091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart Failure Primary Prevention: What Does SPRINT Add?: Recent Advances in Hypertension.
    Raby K; Rocco M; Oparil S; Gilbert ON; Upadhya B
    Hypertension; 2021 Jun; 77(6):1804-1814. PubMed ID: 33813850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT.
    Upadhya B; Willard JJ; Lovato LC; Rocco MV; Lewis CE; Oparil S; Cushman WC; Bates JT; Bello NA; Aurigemma G; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
    Circ Heart Fail; 2021 Dec; 14(12):e008322. PubMed ID: 34823375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Phenomapping Tool and Clinical Score to Identify Low Diuretic Efficiency in Acute Decompensated Heart Failure.
    Segar MW; Khan MS; Patel KV; Butler J; Ravichandran AK; Walsh MN; Willett D; Fonarow GC; Drazner MH; Mentz RJ; Hall J; Farr MA; Hedayati SS; Yancy C; Allen LA; Tang WHW; Pandey A
    JACC Heart Fail; 2024 Mar; 12(3):508-520. PubMed ID: 38099890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint Association of Albuminuria and Left Ventricular Hypertrophy With Incident Heart Failure in Adults at High Risk With Hypertension: A Systolic Blood Pressure Intervention Trial Substudy.
    Ahmad MI; Kazibwe R; Soliman MZ; Singh S; Chen LY; Soliman EZ
    Am J Cardiol; 2023 Dec; 208():75-82. PubMed ID: 37820550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Diuretics in Cardiovascular Events and Mortality in Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis.
    Bansal S; Boucher R; Shen J; Wei G; Chertow GM; Whelton PK; Cushman WC; Cheung AK; Beddhu S;
    Clin J Am Soc Nephrol; 2024 May; 19(5):620-627. PubMed ID: 38262377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review and Meta-Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure.
    Steuber TD; Janzen KM; Howard ML
    Pharmacotherapy; 2020 Sep; 40(9):924-935. PubMed ID: 32639593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Intensive Blood Pressure Lowering on Left Ventricular Hypertrophy in Patients With Hypertension: SPRINT (Systolic Blood Pressure Intervention Trial).
    Soliman EZ; Ambrosius WT; Cushman WC; Zhang ZM; Bates JT; Neyra JA; Carson TY; Tamariz L; Ghazi L; Cho ME; Shapiro BP; He J; Fine LJ; Lewis CE;
    Circulation; 2017 Aug; 136(5):440-450. PubMed ID: 28512184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension. SHEP Cooperative Research Group.
    Kostis JB; Davis BR; Cutler J; Grimm RH; Berge KG; Cohen JD; Lacy CR; Perry HM; Blaufox MD; Wassertheil-Smoller S; Black HR; Schron E; Berkson DM; Curb JD; Smith WM; McDonald R; Applegate WB
    JAMA; 1997 Jul; 278(3):212-6. PubMed ID: 9218667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adding nitroglycerin to early diuretic therapy on the morbidity and mortality of patients with chronic kidney disease presenting with acute decompensated heart failure.
    Aziz EF; Kukin M; Javed F; Pratap B; Sabharwal MS; Tormey D; Frankenberger O; Herzog E
    Hosp Pract (1995); 2011 Feb; 39(1):126-32. PubMed ID: 21441767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
    Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
    PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Felodipine extended release versus conventional diuretic therapy for the treatment of systolic hypertension in elderly patients. The National Trial Group.
    McClennen W; Wilson T
    Clin Invest Med; 1998 Jun; 21(3):142-50. PubMed ID: 9627768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of continuous infusion loop diuretics in patients with acute decompensated heart failure with hypoalbuminemia.
    Bleske BE; Clark MM; Wu AH; Dorsch MP
    J Cardiovasc Pharmacol Ther; 2013 Jul; 18(4):334-7. PubMed ID: 23424098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint Association of Albuminuria and Left Ventricular Hypertrophy with Incident Heart Failure in High-Risk Adults with Hypertension: a SPRINT substudy.
    Ahmad MI; Kazibwe R; Soliman MZ; Singh S; Chen LY; Soliman EZ
    medRxiv; 2023 Jul; ():. PubMed ID: 37461491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Intensive Versus Standard Blood Pressure Management by Tertiles of Blood Pressure in SPRINT (Systolic Blood Pressure Intervention Trial).
    Shapiro BP; Ambrosius WT; Blackshear JL; Cushman WC; Whelton PK; Oparil S; Beddhu S; Dwyer JP; Gren LH; Kostis WJ; Lioudis M; Pisoni R; Rosendorff C; Haley WE;
    Hypertension; 2018 Jun; 71(6):1064-1074. PubMed ID: 29712745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of blood pressure-lowering treatment by the levels of baseline Framingham risk score: A post hoc analysis of the Systolic Blood Pressure Intervention Trial (SPRINT).
    Zhang L; Sun X; Liao L; Zhang S; Zhou H; Zhong X; Zhuang X; Liao X
    J Clin Hypertens (Greenwich); 2019 Dec; 21(12):1813-1820. PubMed ID: 31670874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Individualising intensive systolic blood pressure reduction in hypertension using computational trial phenomaps and machine learning: a post-hoc analysis of randomised clinical trials.
    Oikonomou EK; Spatz ES; Suchard MA; Khera R
    Lancet Digit Health; 2022 Nov; 4(11):e796-e805. PubMed ID: 36307193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated intra-abdominal pressure in acute decompensated heart failure: a potential contributor to worsening renal function?
    Mullens W; Abrahams Z; Skouri HN; Francis GS; Taylor DO; Starling RC; Paganini E; Tang WH
    J Am Coll Cardiol; 2008 Jan; 51(3):300-6. PubMed ID: 18206740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
    Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
    PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.